Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?

C. Nieder*, M.P. Mehta, M. Guckenberger, L.E. Gaspar, C.G. Rusthoven, A. Sahgal, A.L. Grosu, D. De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)17-20
Number of pages4
JournalRadiotherapy and Oncology
Volume159
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • Brain metastases
  • Extracranial metastases
  • Prognostic score
  • Radiotherapy
  • Survival prediction
  • GRADED PROGNOSTIC ASSESSMENT
  • PERFORMANCE STATUS ASSESSMENT
  • CELL LUNG-CANCER
  • STEREOTACTIC RADIOSURGERY
  • OLIGOMETASTATIC DISEASE
  • SUPPORTIVE CARE
  • RECOMMENDATIONS
  • RADIOTHERAPY
  • BIOMARKER
  • PHASE-3

Cite this